| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. (OTLK) has 10 insiders with recent SEC Form 4 filings, including 16 buys and 1 sell. OTLK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.46M | $5.46M | +24.03M | |
| CEO | 800.0K | $1.26M | - | |
| Dir | 423.7K | $669.4K | +400.0K | |
| Dir | 286.7K | $453.0K | - | |
| Dir | 117.3K | $185.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2020 | Syntone Ventures LLC | 10% Owner | Buy | 823,045 | $1.22 | $999,999.68 | +5.1% | |
| Sep 18, 2019 | Kenyon Lawrence A | CEO, Pres, CFO, Treas &Secy | Sell | 1,350 | $1.70 | $2,295.00 | -1.6% | |
| Feb 7, 2019 | Kenyon Lawrence A | CEO, Pres, CFO, Treas &Secy | Buy | 25,000 | $0.90 | $22,380.00 | +43.7% | |
| Feb 4, 2019 | Hilzinger Kurt J | Director | Buy | 5,983 | $0.80 | $4,786.40 | +3.3% | |
| Feb 1, 2019 | Hilzinger Kurt J | Director | Buy | 19,390 | $0.75 | $14,559.80 | +3.9% | |
| Jan 29, 2019 | Hilzinger Kurt J | Director | Buy | 32,112 | $0.71 | $22,690.96 | +7.6% | |
| Jan 23, 2019 | Hilzinger Kurt J | Director | Buy | 13,015 | $0.68 | $8,827.54 | +5.4% | |
| Jan 17, 2019 | Hilzinger Kurt J | Director | Buy | 3,100 | $0.69 | $2,131.00 | +1.4% | |
| Jan 15, 2019 | Mohan Pankaj | Director, 10% Owner | Buy | 8,000 | $0.68 | $5,440.00 | +0.1% | |
| Jan 15, 2019 | Hilzinger Kurt J | Director | Buy | 6,665 | $0.71 | $4,709.49 | +3.1% |